The global Aneurysmal Subarachnoid Hemorrhage market was valued at US$ 151.9 million in 2023 and is anticipated to reach US$ 175.3 million by 2030, witnessing a CAGR of 2.0% during the forecast period 2024-2030.

Aneurysmal Subarachnoid Hemorrhage Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Aneurysmal Subarachnoid Hemorrhage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aneurysmal Subarachnoid Hemorrhage.

Report Scope

The Aneurysmal Subarachnoid Hemorrhage market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aneurysmal Subarachnoid Hemorrhage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Aneurysmal Subarachnoid Hemorrhage companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Aneurysmal Subarachnoid Hemorrhage Market Report

Report Metric	Details
Report Name	Aneurysmal Subarachnoid Hemorrhage Market
Accounted market size in 2023	US$ 151.9 million
Forecasted market size in 2030	US$ 175.3 million
CAGR	2.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Computed Tomography (CT) Scan Magnetic Resonance Imaging (MRI) Lumbar Puncture Xanthochromia Cerebral Angiography Transcranial Doppler Ultrasound
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Edge Therapeutics, Actelion Pharmaceuticals, Arbor Pharmaceuticals, Mayfield Brain & Spine, Europa Group, GE, Philips, Siemens, Trivitron, Toshiba
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Aneurysmal Subarachnoid Hemorrhage companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Aneurysmal Subarachnoid Hemorrhage Market growing?

Ans: The Aneurysmal Subarachnoid Hemorrhage Market witnessing a CAGR of 2.0% during the forecast period 2024-2030.

What is the Aneurysmal Subarachnoid Hemorrhage Market size in 2030?

Ans: The Aneurysmal Subarachnoid Hemorrhage Market size in 2030 will be US$ 175.3 million.

Who are the main players in the Aneurysmal Subarachnoid Hemorrhage Market report?

Ans: The main players in the Aneurysmal Subarachnoid Hemorrhage Market are Edge Therapeutics, Actelion Pharmaceuticals, Arbor Pharmaceuticals, Mayfield Brain & Spine, Europa Group, GE, Philips, Siemens, Trivitron, Toshiba

What are the Application segmentation covered in the Aneurysmal Subarachnoid Hemorrhage Market report?

Ans: The Applications covered in the Aneurysmal Subarachnoid Hemorrhage Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Aneurysmal Subarachnoid Hemorrhage Market report?

Ans: The Types covered in the Aneurysmal Subarachnoid Hemorrhage Market report are Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Lumbar Puncture, Xanthochromia, Cerebral Angiography, Transcranial Doppler Ultrasound

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Computed Tomography (CT) Scan

1.2.3 Magnetic Resonance Imaging (MRI)

1.2.4 Lumbar Puncture

1.2.5 Xanthochromia

1.2.6 Cerebral Angiography

1.2.7 Transcranial Doppler Ultrasound

1.3 Market by Application

1.3.1 Global Aneurysmal Subarachnoid Hemorrhage Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Aneurysmal Subarachnoid Hemorrhage Market Perspective (2019-2030)

2.2 Aneurysmal Subarachnoid Hemorrhage Growth Trends by Region

2.2.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Region (2019-2024)

2.2.3 Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Region (2025-2030)

2.3 Aneurysmal Subarachnoid Hemorrhage Market Dynamics

2.3.1 Aneurysmal Subarachnoid Hemorrhage Industry Trends

2.3.2 Aneurysmal Subarachnoid Hemorrhage Market Drivers

2.3.3 Aneurysmal Subarachnoid Hemorrhage Market Challenges

2.3.4 Aneurysmal Subarachnoid Hemorrhage Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Aneurysmal Subarachnoid Hemorrhage Players by Revenue

3.1.1 Global Top Aneurysmal Subarachnoid Hemorrhage Players by Revenue (2019-2024)

3.1.2 Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Players (2019-2024)

3.2 Global Aneurysmal Subarachnoid Hemorrhage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Aneurysmal Subarachnoid Hemorrhage Revenue

3.4 Global Aneurysmal Subarachnoid Hemorrhage Market Concentration Ratio

3.4.1 Global Aneurysmal Subarachnoid Hemorrhage Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Aneurysmal Subarachnoid Hemorrhage Revenue in 2023

3.5 Aneurysmal Subarachnoid Hemorrhage Key Players Head office and Area Served

3.6 Key Players Aneurysmal Subarachnoid Hemorrhage Product Solution and Service

3.7 Date of Enter into Aneurysmal Subarachnoid Hemorrhage Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Aneurysmal Subarachnoid Hemorrhage Breakdown Data by Type

4.1 Global Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Type (2019-2024)

4.2 Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Type (2025-2030)

5 Aneurysmal Subarachnoid Hemorrhage Breakdown Data by Application

5.1 Global Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Application (2019-2024)

5.2 Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size (2019-2030)

6.2 North America Aneurysmal Subarachnoid Hemorrhage Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024)

6.4 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Aneurysmal Subarachnoid Hemorrhage Market Size (2019-2030)

7.2 Europe Aneurysmal Subarachnoid Hemorrhage Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024)

7.4 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size (2019-2030)

8.2 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2019-2024)

8.4 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size (2019-2030)

9.2 Latin America Aneurysmal Subarachnoid Hemorrhage Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024)

9.4 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size (2019-2030)

10.2 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024)

10.4 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Edge Therapeutics

11.1.1 Edge Therapeutics Company Detail

11.1.2 Edge Therapeutics Business Overview

11.1.3 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Introduction

11.1.4 Edge Therapeutics Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

11.1.5 Edge Therapeutics Recent Development

11.2 Actelion Pharmaceuticals

11.2.1 Actelion Pharmaceuticals Company Detail

11.2.2 Actelion Pharmaceuticals Business Overview

11.2.3 Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Introduction

11.2.4 Actelion Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

11.2.5 Actelion Pharmaceuticals Recent Development

11.3 Arbor Pharmaceuticals

11.3.1 Arbor Pharmaceuticals Company Detail

11.3.2 Arbor Pharmaceuticals Business Overview

11.3.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Introduction

11.3.4 Arbor Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

11.3.5 Arbor Pharmaceuticals Recent Development

11.4 Mayfield Brain & Spine

11.4.1 Mayfield Brain & Spine Company Detail

11.4.2 Mayfield Brain & Spine Business Overview

11.4.3 Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Introduction

11.4.4 Mayfield Brain & Spine Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

11.4.5 Mayfield Brain & Spine Recent Development

11.5 Europa Group

11.5.1 Europa Group Company Detail

11.5.2 Europa Group Business Overview

11.5.3 Europa Group Aneurysmal Subarachnoid Hemorrhage Introduction

11.5.4 Europa Group Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

11.5.5 Europa Group Recent Development

11.6 GE

11.6.1 GE Company Detail

11.6.2 GE Business Overview

11.6.3 GE Aneurysmal Subarachnoid Hemorrhage Introduction

11.6.4 GE Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

11.6.5 GE Recent Development

11.7 Philips

11.7.1 Philips Company Detail

11.7.2 Philips Business Overview

11.7.3 Philips Aneurysmal Subarachnoid Hemorrhage Introduction

11.7.4 Philips Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

11.7.5 Philips Recent Development

11.8 Siemens

11.8.1 Siemens Company Detail

11.8.2 Siemens Business Overview

11.8.3 Siemens Aneurysmal Subarachnoid Hemorrhage Introduction

11.8.4 Siemens Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

11.8.5 Siemens Recent Development

11.9 Trivitron

11.9.1 Trivitron Company Detail

11.9.2 Trivitron Business Overview

11.9.3 Trivitron Aneurysmal Subarachnoid Hemorrhage Introduction

11.9.4 Trivitron Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

11.9.5 Trivitron Recent Development

11.10 Toshiba

11.10.1 Toshiba Company Detail

11.10.2 Toshiba Business Overview

11.10.3 Toshiba Aneurysmal Subarachnoid Hemorrhage Introduction

11.10.4 Toshiba Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

11.10.5 Toshiba Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Edge Therapeutics

Actelion Pharmaceuticals

Arbor Pharmaceuticals

Mayfield Brain & Spine

List of Tables

Table 1. Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Computed Tomography (CT) Scan

Table 3. Key Players of Magnetic Resonance Imaging (MRI)

Table 4. Key Players of Lumbar Puncture

Table 5. Key Players of Xanthochromia

Table 6. Key Players of Cerebral Angiography

Table 7. Key Players of Transcranial Doppler Ultrasound

Table 8. Global Aneurysmal Subarachnoid Hemorrhage Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Aneurysmal Subarachnoid Hemorrhage Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Region (2019-2024)

Table 12. Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Region (2025-2030)

Table 14. Aneurysmal Subarachnoid Hemorrhage Market Trends

Table 15. Aneurysmal Subarachnoid Hemorrhage Market Drivers

Table 16. Aneurysmal Subarachnoid Hemorrhage Market Challenges

Table 17. Aneurysmal Subarachnoid Hemorrhage Market Restraints

Table 18. Global Aneurysmal Subarachnoid Hemorrhage Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Players (2019-2024)

Table 20. Global Top Aneurysmal Subarachnoid Hemorrhage Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage as of 2023)

Table 21. Ranking of Global Top Aneurysmal Subarachnoid Hemorrhage Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Aneurysmal Subarachnoid Hemorrhage Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Aneurysmal Subarachnoid Hemorrhage Product Solution and Service

Table 25. Date of Enter into Aneurysmal Subarachnoid Hemorrhage Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Aneurysmal Subarachnoid Hemorrhage Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Type (2019-2024)

Table 29. Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Type (2025-2030)

Table 31. Global Aneurysmal Subarachnoid Hemorrhage Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Application (2019-2024)

Table 33. Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Application (2025-2030)

Table 35. North America Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2025-2030) & (US$ Million)

Table 50. Edge Therapeutics Company Detail

Table 51. Edge Therapeutics Business Overview

Table 52. Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Product

Table 53. Edge Therapeutics Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024) & (US$ Million)

Table 54. Edge Therapeutics Recent Development

Table 55. Actelion Pharmaceuticals Company Detail

Table 56. Actelion Pharmaceuticals Business Overview

Table 57. Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Product

Table 58. Actelion Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024) & (US$ Million)

Table 59. Actelion Pharmaceuticals Recent Development

Table 60. Arbor Pharmaceuticals Company Detail

Table 61. Arbor Pharmaceuticals Business Overview

Table 62. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Product

Table 63. Arbor Pharmaceuticals Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024) & (US$ Million)

Table 64. Arbor Pharmaceuticals Recent Development

Table 65. Mayfield Brain & Spine Company Detail

Table 66. Mayfield Brain & Spine Business Overview

Table 67. Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Product

Table 68. Mayfield Brain & Spine Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024) & (US$ Million)

Table 69. Mayfield Brain & Spine Recent Development

Table 70. Europa Group Company Detail

Table 71. Europa Group Business Overview

Table 72. Europa Group Aneurysmal Subarachnoid Hemorrhage Product

Table 73. Europa Group Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024) & (US$ Million)

Table 74. Europa Group Recent Development

Table 75. GE Company Detail

Table 76. GE Business Overview

Table 77. GE Aneurysmal Subarachnoid Hemorrhage Product

Table 78. GE Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024) & (US$ Million)

Table 79. GE Recent Development

Table 80. Philips Company Detail

Table 81. Philips Business Overview

Table 82. Philips Aneurysmal Subarachnoid Hemorrhage Product

Table 83. Philips Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024) & (US$ Million)

Table 84. Philips Recent Development

Table 85. Siemens Company Detail

Table 86. Siemens Business Overview

Table 87. Siemens Aneurysmal Subarachnoid Hemorrhage Product

Table 88. Siemens Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024) & (US$ Million)

Table 89. Siemens Recent Development

Table 90. Trivitron Company Detail

Table 91. Trivitron Business Overview

Table 92. Trivitron Aneurysmal Subarachnoid Hemorrhage Product

Table 93. Trivitron Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024) & (US$ Million)

Table 94. Trivitron Recent Development

Table 95. Toshiba Company Detail

Table 96. Toshiba Business Overview

Table 97. Toshiba Aneurysmal Subarachnoid Hemorrhage Product

Table 98. Toshiba Revenue in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024) & (US$ Million)

Table 99. Toshiba Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Aneurysmal Subarachnoid Hemorrhage Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Type: 2023 VS 2030

Figure 3. Computed Tomography (CT) Scan Features

Figure 4. Magnetic Resonance Imaging (MRI) Features

Figure 5. Lumbar Puncture Features

Figure 6. Xanthochromia Features

Figure 7. Cerebral Angiography Features

Figure 8. Transcranial Doppler Ultrasound Features

Figure 9. Global Aneurysmal Subarachnoid Hemorrhage Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Application: 2023 VS 2030

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Others Case Studies

Figure 14. Aneurysmal Subarachnoid Hemorrhage Report Years Considered

Figure 15. Global Aneurysmal Subarachnoid Hemorrhage Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Aneurysmal Subarachnoid Hemorrhage Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Region: 2023 VS 2030

Figure 18. Global Aneurysmal Subarachnoid Hemorrhage Market Share by Players in 2023

Figure 19. Global Top Aneurysmal Subarachnoid Hemorrhage Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Aneurysmal Subarachnoid Hemorrhage Revenue in 2023

Figure 21. North America Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Aneurysmal Subarachnoid Hemorrhage Market Share by Country (2019-2030)

Figure 23. United States Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Aneurysmal Subarachnoid Hemorrhage Market Share by Country (2019-2030)

Figure 27. Germany Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Share by Region (2019-2030)

Figure 35. China Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Aneurysmal Subarachnoid Hemorrhage Market Share by Country (2019-2030)

Figure 43. Mexico Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Share by Country (2019-2030)

Figure 47. Turkey Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Edge Therapeutics Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

Figure 50. Actelion Pharmaceuticals Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

Figure 51. Arbor Pharmaceuticals Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

Figure 52. Mayfield Brain & Spine Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

Figure 53. Europa Group Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

Figure 54. GE Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

Figure 55. Philips Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

Figure 56. Siemens Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

Figure 57. Trivitron Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

Figure 58. Toshiba Revenue Growth Rate in Aneurysmal Subarachnoid Hemorrhage Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Respiratory Infection Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39D3651

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Internal Neuromodulation Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24F2529

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions